Karyopharm Therapeutics (KPTI) Announces Presentation of Selinexor Phase 2 Data; Lower Adverse Effects Noted
Go back to Karyopharm Therapeutics (KPTI) Announces Presentation of Selinexor Phase 2 Data; Lower Adverse Effects Noted| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 1.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $19.41 | |||
| Open | $1.10 | 52 Week Low | $4.83 | |||
| Day High | $1.15 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $-2.74 | |||
| Volume | 1,203,579 | |||||
